Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 2Gynecologic 1

Conditions

Ovarian Neoplasms 92Fallopian Tube Neoplasms 25Breast Neoplasms 21Endometrial Neoplasms 19Carcinoma, Ovarian Epithelial 12Triple Negative Breast Neoplasms 7Prostatic Neoplasms 7Pancreatic Neoplasms 7Neoplasms 6Fanconi Anemia, Complementation Group D1 5Uterine Cervical Neoplasms 4Recurrence 4Neoplasm Metastasis 4Carcinoma, Renal Cell 3Uterine Neoplasms 2Stomach Neoplasms 2Peritoneal Neoplasms 2Ovarian Diseases 2Carcinosarcoma 2Carcinoma, Non-Small-Cell Lung 2Urogenital Neoplasms 1Triple Negative Metastatic Breast Cancer 1Thyroid Neoplasms 1Small Cell Lung Carcinoma 1Sarcoma 1Relapsed Ovarian Cancers Patients 1Recurrent Ovarian High Grade Serous Adenocarcinoma 1Prostatic Neoplasms, Castration-Resistant 1Platinum-sensitive Ovarian Cancer 1Platinum-Refractory Fallopian Tube Carcinoma 1

Interventions

Nivolumab 3Specimen Handling 2Magnetic Resonance Spectroscopy 2Ipilimumab 2CTLA-4 Antigen 2sintilimab 1serabelisib 1sapanisertib 1rucaparib 1pembrolizumab 1palbociclib 1olaparib 1durvalumab 1ceralasertib 1adavosertib 1Therapeutics 1Restraint, Physical 1Radiation, Ionizing 1Radiation 1Platinum 1Paclitaxel 1Megestrol Acetate 1Medroxyprogesterone Acetate 1Fulvestrant 1Congresses as Topic 1Cisplatin 1Carboplatin 11,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Carcinoma, Endometrioid × olaparib × Gynecologic × Clear all
NCT04065269 2026-02-20

ATARI

Institute of Cancer Research, United Kingdom

Phase 2 Active not recruiting
174 enrolled
GynecologicSarcoma

Carcinosarcoma, Uterine Cervical Neoplasms, Endometrial Neoplasms, Carcinoma, Endometrioid

Data powered by HemOnc (CC BY 4.0) Colophon âš¡